Michael David Testa

Director/Board Member at

Hemanext, Inc.

Finance

Health Technology

Profile

Michael David Testa is currently a Director at Hemanext, Inc. He previously worked as Vice Chairman & Vice President at T.
Rowe Price Group, Inc. and as Chief Investment Officer at T.
Rowe Price Associates, Inc. (Investment Management).

Michael David Testa active positions

Companies	Position	Start
Hemanext, Inc. Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells	Director/Board Member	-

All active positions of Michael David Testa

Former positions of Michael David Testa

Companies	Position	End
T. ROWE PRICE GROUP, INC.	Director/Board Member	-
T. Rowe Price Associates, Inc. (IM) T. Rowe Price Associates, Inc. (IM) Investment ManagersFinance Price Associates uses a complex and multifaceted approach to investment analysis and asset management decisions. They integrate ESG factors into their investment research process. The firm focuses on the ESG factors they consider most likely to have a material impact on the performance of securities in client accounts. Price Associates also focuses on their analytical process on three areas of research: the industry, the contracts issued, and the creditworthiness of each individual issuer.	Head-Equity Investments	-

See the detail of Michael David Testa's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael David Testa's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
T. Rowe Price Associates, Inc. (IM) T. Rowe Price Associates, Inc. (IM) Investment ManagersFinance Price Associates uses a complex and multifaceted approach to investment analysis and asset management decisions. They integrate ESG factors into their investment research process. The firm focuses on the ESG factors they consider most likely to have a material impact on the performance of securities in client accounts. Price Associates also focuses on their analytical process on three areas of research: the industry, the contracts issued, and the creditworthiness of each individual issuer.	Finance
T. Rowe Price Group, Inc. T. Rowe Price Group, Inc. Investment ManagersFinance Functions as a financial services holding company through its subsidiaries provides investment advisory services	Finance
Hemanext, Inc. Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells	Health Technology